Clinical Trial Update: A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males [Phase 1]

View source ↗

Summary

Phase 1 mass-balance study in healthy males to characterize recovery, metabolite profile, and identify [14C]-APX001 (fosmanogepix); the trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection

Drugs mentioned

• APX001 (fosmanogepix)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Fungal Infection | Phase 1 | Status: COMPLETED